Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7308)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2017 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ben-Horin S, Andrews JM, Katsanos KH, Rieder F, Steinwurz F, Karmiris K, Cheon JH, Moran GW, Cesarini M, Stone CD, Schwartz D, Protic M, Roblin X, Roda G, Chen MH, Har-Noy O, Bernstein CN. Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice. World J Gastroenterol 2017; 23(16): 2995-3002 [PMID: 28522918 DOI: 10.3748/wjg.v23.i16.2995] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i16/2995.htm |
| Number | Citing Articles |
| 1 |
Seth R. Shaffer, Elbert Huang, Shivani Patel, David T. Rubin. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. American Journal of Gastroenterology 2021; 116(1): 125 doi: 10.14309/ajg.0000000000000847
|
| 2 |
Jingwei Zhang, Wei Wang, Shenglong Zhu, Yongquan Chen. Increased SERPINA3 Level Is Associated with Ulcerative Colitis. Diagnostics 2021; 11(12): 2371 doi: 10.3390/diagnostics11122371
|
| 3 |
Youn I Choi, Tae Jun Kim, Dong Kyun Park, Jun-won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease. International Journal of Colorectal Disease 2019; 34(10): 1713 doi: 10.1007/s00384-019-03368-1
|
| 4 |
Siddharth Singh, James A. Proudfoot, Parambir S. Dulai, Vipul Jairath, Mathurin Fumery, Ronghui Xu, Brian G. Feagan, William J. Sandborn. No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials. American Journal of Gastroenterology 2018; 113(8): 1197 doi: 10.1038/s41395-018-0144-2
|
| 5 |
Ji-Long Wang, Yun-Jiu Gan, Shoaib Iqbal, Wei Jiang, You-Yong Yuan, Jun Wang. Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy. Biomaterials Science 2018; 6(7): 1916 doi: 10.1039/C8BM00463C
|
| 6 |
Haojie Yang, Ying Li, Sichen Shen, Dan Gan, Changpeng Han, Jiong Wu, Zhenyi Wang. Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7870424
|
| 7 |
Rayko Lazcano-Silveira, Xiaoxiao Jia, Kaixuan Liu, Honggang Liu, Xinrong Li, Mizhou Hui. Carbon 60 Dissolved in Grapeseed Oil Inhibits Dextran Sodium Sulfate-Induced Experimental Colitis. Journal of Inflammation Research 2022; : 4185 doi: 10.2147/JIR.S366886
|
| 8 |
Shomron Ben-Horin, Ofir Har-Noy, Konstantinos H. Katsanos, Xavier Roblin, Minhu Chen, Xiang Gao, Doron Schwartz, Jae Hee Cheon, Monica Cesarini, Daniela Bojic, Marijana Protic, Angeliki Theodoropoulou, Heba Abu-Kaf, Tal Engel, Jian Tang, Pauline Veyrard, Xiaoqing Lin, Ren Mao, Dimitrios Christodoulou, Konstantinos Karmiris, Tamara Knezevic-Ivanovski. Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2022; 20(12): 2868 doi: 10.1016/j.cgh.2022.02.055
|